
USFDA APPLICATION NUMBER - 203496 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 1MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| treprostinil(UNII: RUM6K67ESG) (treprostinil - UNII:RUM6K67ESG) | treprostinil | 2.5mg |
Inactive Ingredients
| Ingredient Name | Avera McKennan Hospital |
|---|---|
| Alcohol(3K9958V90M) | |
| BUTYL ALCOHOL(8PJ61P6TS3) | |
| Cellulose Acetate(3J2P07GVB6) | |
| Ferric Oxide Red(1K09F3G675) | |
| Ferrosoferric Oxide(XM0M87F357) | |
| Isopropyl Alcohol(ND2M416302) | |
| Magnesium Stearate(70097M6I30) | |
| Maltodextrin(7CVR7L4A2D) | |
| Polyethylene Glycol 3350(G2M7P15E5P) | |
| Polyvinyl alcohol, unspecified(532B59J990) | |
| Propylene Glycol(6DC9Q167V3) | |
| Shellac(46N107B71O) | |
| Sodium Lauryl Sulfate(368GB5141J) | |
| Talc(7SEV7J4R1U) | |
| Titanium Dioxide(15FIX9V2JP) | |
| Triethyl Citrate(8Z96QXD6UM) | |
| Xylitol(VCQ006KQ1E) |